We observed an increasing trend in hospital contact‐based UTI HRs in the SGLT2i vs .
← all excerpts
Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium-glucose cotransporter 2 inhibitor users.
1
—
—